Kathryn DiMarco - Feb 9, 2024 Form 4 Insider Report for Organon & Co. (OGN)

Role
Corporate Controller
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Kathryn DiMarco
Stock symbol
OGN
Transactions as of
Feb 9, 2024
Transactions value $
-$12,069
Form type
4
Date filed
2/13/2024, 04:16 PM
Previous filing
May 8, 2023
Next filing
Mar 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise $0 +1.87K +24.89% $0.00 9.39K Feb 9, 2024 Direct F1
transaction OGN Common Stock Tax liability -$12.1K -740 -7.88% $16.31 8.65K Feb 9, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -1.87K -100% $0.00* 0 Feb 9, 2024 Common Stock 1.87K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.
F2 On each of February 9, 2022, February 9, 2023, and February 9, 2024, one-third of the RSUs vested.